{"id":1068,"date":"2018-10-05T08:45:52","date_gmt":"2018-10-05T06:45:52","guid":{"rendered":"https:\/\/www.ggkmedia.com\/?p=1068"},"modified":"2020-03-31T03:30:22","modified_gmt":"2020-03-31T01:30:22","slug":"klinisk-provning-av-inofer-har-startats","status":"publish","type":"post","link":"https:\/\/www.drugsson.com\/sv\/klinisk-provning-av-inofer-har-startats\/","title":{"rendered":"Klinisk pr\u00f6vning av Inofer har startats"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-background-repeat:repeat;--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:90px;--awb-padding-bottom:90px;--awb-background-color:#eaf7ff;--awb-border-sizes-top:0px;--awb-border-sizes-bottom:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_2_3 2_3 fusion-two-third\" style=\"--awb-padding-top:50px;--awb-padding-right:50px;--awb-padding-bottom:30px;--awb-padding-left:50px;--awb-bg-color:#ffffff;--awb-bg-color-hover:#ffffff;--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-1\"><h3 style=\"text-align: left;\">Klinisk pr\u00f6vning av Inofer har startats<\/h3>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-last\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_2_3 2_3 fusion-two-third\" style=\"--awb-bg-size:cover;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-last\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-6 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-7 fusion_builder_column_2_3 2_3 fusion-two-third\" style=\"--awb-padding-top:50px;--awb-padding-right:50px;--awb-padding-bottom:50px;--awb-padding-left:50px;--awb-bg-color:#ffffff;--awb-bg-color-hover:#ffffff;--awb-bg-size:cover;--awb-border-color:#25afb4;--awb-border-bottom:8px;--awb-border-style:solid;width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );margin-right: 4%;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-2\"><p>Den kliniska studien f\u00f6r j\u00e4rntabletterna Inofer, som Drugsson AB (dotterbolag till Double Bond Pharmaceutical) har r\u00e4ttigheter f\u00f6r i Sverige, Norge, Danmark och Finland, har nu startat. En klinisk pr\u00f6vning av Inofer godk\u00e4ndes, som tidigare rapporterats, av L\u00e4kemedelsverket och forskningsetikn\u00e4mnden den 20e juni och ig\u00e5r, den 4 oktober, har f\u00f6rsta patienten f\u00e5tt behandling med Inofer-tabletter. Studien utf\u00f6rs vid Skellefte\u00e5 lasarett och leds av \u00f6verl\u00e4kare Kurt Boman, senior professor vid Ume\u00e5 universitet.<\/p>\n<p>\u201dVi hoppas att studien fortl\u00f6per som planerat och ser fram emot att f\u00e5 resultat som visar att Inofer ger en \u00f6kning av j\u00e4rnniv\u00e5erna hos hj\u00e4rtsviktspatienter.\u201d-kommenterar Igor Lokot, VD f\u00f6r Double Bond Pharmaceutical och Drugsson AB.<\/p>\n<p><strong>Mer om j\u00e4rnbrist och hj\u00e4rtsvikt:\u00a0<\/strong>Omkring 15 % av v\u00e4rldens befolkning lider av j\u00e4rnbrist. Cirka 250 000 personer i Sverige har symptomgivande hj\u00e4rtsvikt och h\u00e4lften av dessa har samtidig j\u00e4rnbrist. Denna kombination av diagnoser leder till \u00f6kade symtom och ofta till sjukhusinl\u00e4ggningar. Behandling med vanliga j\u00e4rntabletter fungerar inte p\u00e5 grund av otillr\u00e4ckligt upptag fr\u00e5n tarmen. F\u00f6r att behandla j\u00e4rnbrist hos hj\u00e4rtsviktpatienter m\u00e5ste d\u00e4rf\u00f6r i dagsl\u00e4get j\u00e4rninneh\u00e5llande l\u00e4kemedel injiceras intraven\u00f6st p\u00e5 en v\u00e5rdinr\u00e4ttning, vilket \u00e4r resurskr\u00e4vande. Om det visar sig att ferrosuccinat-tabletter kan behandla j\u00e4rnbrist hos hj\u00e4rtsviktpatienter skulle det inneb\u00e4ra en betydande vinst f\u00f6r patienterna och f\u00f6r sjukv\u00e5rden eftersom behandlingen i s\u00e5 fall kan genomf\u00f6ras i hemmet.<\/p>\n<\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;margin-top:40px;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-text fusion-text-3\"><h4>Nyhetsk\u00e4lla<\/h4>\n<\/div><div class=\"fusion-text fusion-text-4\"><p><a href=\"https:\/\/www.spotlightstockmarket.com\/sv\/market-overview\/nyheter\/nyhets-artikel\/?id=46969&amp;publisher=370\" target=\"_blank\" rel=\"noopener noreferrer\">Spotlight<\/a><\/p>\n<\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;margin-top:40px;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-sharing-box fusion-sharing-box-1 boxed-icons has-taglines layout-floated layout-medium-floated layout-small-floated\" style=\"background-color:#f6f6f6;--awb-layout:row;--awb-alignment-small:space-between;\" data-title=\"Klinisk pr\u00f6vning av Inofer har startats\" data-description=\"Klinisk pr\u00f6vning av Inofer har startats    Den kliniska studien f\u00f6r j\u00e4rntabletterna Inofer, som Drugsson AB (dotterbolag till Double Bond Pharmaceutical) har r\u00e4ttigheter f\u00f6r i Sverige, Norge, Danmark och Finland, har nu startat. En klinisk pr\u00f6vning av Inofer godk\u00e4ndes, som tidigare rapporterats, av L\u00e4kemedelsverket och forskningsetikn\u00e4mnden den\" data-link=\"https:\/\/www.drugsson.com\/sv\/klinisk-provning-av-inofer-har-startats\/\"><h4 class=\"tagline\" style=\"color:#4c5166;\">Dela inl\u00e4gget<\/h4><div class=\"fusion-social-networks sharingbox-shortcode-icon-wrapper sharingbox-shortcode-icon-wrapper-1 boxed-icons\"><span><a href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.drugsson.com%2Fsv%2Fklinisk-provning-av-inofer-har-startats%2F&amp;t=Klinisk%20pr%C3%B6vning%20av%20Inofer%20har%20startats\" target=\"_blank\" rel=\"noreferrer\" title=\"Facebook\" aria-label=\"Facebook\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"Facebook\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-facebook awb-icon-facebook\" style=\"color:#ffffff;background-color:#3b5998;border-color:#3b5998;border-radius:0px;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/x.com\/intent\/post?text=Klinisk%20pr%C3%B6vning%20av%20Inofer%20har%20startats&amp;url=https%3A%2F%2Fwww.drugsson.com%2Fsv%2Fklinisk-provning-av-inofer-har-startats%2F\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"X\" aria-label=\"X\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"X\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-twitter awb-icon-twitter\" style=\"color:#ffffff;background-color:#000000;border-color:#000000;border-radius:0px;\" aria-hidden=\"true\"><\/i><\/a><\/span><span><a href=\"https:\/\/www.linkedin.com\/shareArticle?mini=true&amp;url=https%3A%2F%2Fwww.drugsson.com%2Fsv%2Fklinisk-provning-av-inofer-har-startats%2F&amp;title=Klinisk%20pr%C3%B6vning%20av%20Inofer%20har%20startats&amp;summary=Klinisk%20pr%C3%B6vning%20av%20Inofer%20har%20startats%20%20%20%20%20%20%20%0D%0A%0D%0ADen%20kliniska%20studien%20f%C3%B6r%20j%C3%A4rntabletterna%20Inofer%2C%20som%20Drugsson%20AB%20%28dotterbolag%20till%20Double%20Bond%20Pharmaceutical%29%20har%20r%C3%A4ttigheter%20f%C3%B6r%20i%20Sverige%2C%20Norge%2C%20Danmark%20och%20Finland%2C%20har%20nu%20startat.%20En%20klinisk%20pr%C3%B6vning%20av%20Inofer%20godk%C3%A4ndes%2C%20som%20tidigare%20rapporterats%2C%20av%20L%C3%A4kemedelsverket%20och%20forskningsetikn%C3%A4mnden%20den\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"LinkedIn\" aria-label=\"LinkedIn\" data-placement=\"top\" data-toggle=\"tooltip\" data-title=\"LinkedIn\"><i class=\"fusion-social-network-icon fusion-tooltip fusion-linkedin awb-icon-linkedin\" style=\"color:#ffffff;background-color:#0077b5;border-color:#0077b5;border-radius:0px;\" aria-hidden=\"true\"><\/i><\/a><\/span><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-8 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-last\" style=\"--awb-bg-size:cover;width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19,4],"tags":[],"_links":{"self":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts\/1068"}],"collection":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/comments?post=1068"}],"version-history":[{"count":7,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts\/1068\/revisions"}],"predecessor-version":[{"id":2461,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/posts\/1068\/revisions\/2461"}],"wp:attachment":[{"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/media?parent=1068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/categories?post=1068"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drugsson.com\/sv\/wp-json\/wp\/v2\/tags?post=1068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}